Search PubMed⌕ Search

Biomedical subjects

T Iijima

Publications and source records attributed to T Iijima.

462 records · Page 26Linked to original sources
PubMedDate not supplied

Effects of nicorandil and its interaction with isoproterenol on force of contraction and cyclic nucleotide levels of canine atrial muscle: comparison with carbachol.

Experiments were carried out on isolated canine right atria to investigate the effects of N-(2-hydroxyethyl)nicotinamide nitrate (nicorandil, SG-75) and its interaction with beta-adrenoceptor stimulation on the cyclic nucleotide levels accompanying inotropic changes. The results were compared with those during muscarinic receptor stimulation. The effects of nicorandil were similar to those of carbachol insofar as its negative inotropic effect was accompanied by a significant elevation of cyclic GMP levels in the absence of beta-adrenoceptor stimulation. However, the effects of nicorandil differed strikingly from those of carbachol in that the negative inotropic action of nicorandil was readily counteracted by isoproterenol, while that of carbachol was not. This difference may be ascribed to differences in cyclic AMP metabolism caused by these agents: carbachol but not nicorandil decreased the isoproterenol-induced elevation of cyclic AMP levels. The negative inotropic effects of muscarinic receptor stimulation on canine atria are associated with two different sorts of changes in cyclic nucleotide metabolism, i.e., cyclic GMP elevation and cyclic AMP reduction; nicorandil mimics the former but not the latter process.

Animals↗
PubMedDate not supplied

Pulmonary vasculature in idiopathic dilated cardiomyopathy: a morphometric study.

The pulmonary vascular alterations of seven patients with idiopathic dilated cardiomyopathy (IDC) were morphometrically examined, and the relation between the vascular alterations and morphological status of the hearts was studied. Most patients with IDC showed not only fibrous thickening of small pulmonary veins but also intimal circumferential fibrosis and medial hypertrophy of small pulmonary muscular arteries to various degrees. The histological features of the pulmonary vessels were compatible with hypertensive vascular changes observed in patients with mitral stenosis. There was a significant correlation between medial hypertrophy of the pulmonary muscular arteries and right ventricular hypertrophy. The pulmonary vascular changes in IDC were always associated with left atrioventricular dilatation, but were only found in patients with prominent hypertrophy of the left ventricles. Medial hypertrophy of the pulmonary muscular arteries was related more to left ventricular hypertrophy than to left ventricular dilatation. These findings suggest that the pulmonary vascular changes in IDC are caused by venous pulmonary hypertension, which may be developed at the late stage when left ventricular hypertrophy predominates.

Adult↗
PubMedDate not supplied

MR imaging of Pellegrini-Stieda disease.

OBJECTIVE: To describe the MR imaging of Pellegrini-Stieda disease, a post-traumatic ossification of the medial collateral ligament with typical radiographic findings. METHODS: Coronal and/or axial T2*-weighted field echo and T1-weighted conventional spin echo MR images were obtained with 1.5-Tesla or 0.5-Tesla units. Four patients with radiographic and clinical diagnoses of Pellegrini-Stieda disease were examined. Surgery was performed on one patient, and histopathologic correlation was obtained. RESULTS AND CONCLUSION: Delineating it as a signal void, T2*-weighted MR imaging indicated the precise extent of the osseous fragment in relation to the medial collateral ligament. T1-weighted imaging showed the presence of fatty marrow as a high signal region within the fragment, indicating maturity of the fragment. These findings may help to determine preoperative planning for resection of massive fragments around the ligament. Pellegrini-Stieda disease cannot be considered rare, since it is often encountered in daily MRI examinations.

Adult↗
PubMedDate not supplied

Detection of liver membrane antibodies in patients with non-insulin-dependent diabetes mellitus.

Circulating liver membrane antibodies (LMAb) were examined in 71 patients with non-insulin-dependent diabetes mellitus (NIDDM) without liver dysfunction and 16 cases of KK mouse as a model of obese diabetic animals. LMAb were detected in 10 NIDDM patients (14.1%). Fasting blood glucose, glycosylated serum albumin (G-Alb), and glycosylated hemoglobin A1 (HbA1) levels were compared with LMAb-positive and negative groups. The G-Alb levels and HbA1 levels of the LMAb-positive group were significantly higher (p less than 0.05 and p less than 0.01, respectively) than those of the LMAb-negative group. In addition, there were no differences in histological findings in KK mouse liver between the LMAb-positive and negative cases. These results revealed that the state of continued high blood glucose directly or indirectly influence the autoimmunity and clinical features of NIDDM patients.

Animals↗
PubMedDate not supplied

Induction of endometrial adenocarcinomas in persistent estrous Donryu rats by a single intra-uterine administration of N-ethyl-N'-nitro-N-nitrosoguanidine.

Induction of endometrial adenocarcinomas in persistent estrous Donryu rats by a single intra-uterine administration of N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG) was examined. Female Donryu rats were divided into four groups at 7 weeks of age. Rats in Croup 1 were controls under a 12-h light/12-h dark regimen while Groups 2-4 were persistent estrous animals maintained under 24-h light conditions. At 10 weeks of age, rats in Group 1 and 2 were given a single intra-uterine administration of polyethylene glycol(PEG), and those in Groups 3 and 4 received ENNG(20 mg/kg body weight), dissolved in PEG, in the same manner. Group 4 rats also received an s.c. 17 beta-estradiol(E2) implant one week thereafter. At the termination of the experiment (week 42 after the ENNG-treatment), all surviving rats were killed and the development of uterine proliferative lesions assessed. All groups demonstrated hyperplasias, the incidence and severity being higher in ENNG-treated animals. The incidence of uterine adenocarcinomas in Group 2(2/20, 10%) was slightly higher than that in Group 1(0/16, 0%), although this difference was not significant. In Groups 3(7/19, 37%) and 4(6/20, 30%) statistically significant induction of adenocarcinomas was noted, two lesions in the latter case being very large with prominent invasion of tumor cells into the perimetrium. At 10 and 25 weeks after ENNG-treatment, the E2-progesterone(E2:P) ratios in Groups 2, 3 and 4 were significantly higher than in Group 1.(ABSTRACT TRUNCATED AT 250 WORDS)

Adenocarcinoma↗
PubMedDate not supplied

Treatment of patients with chronic hepatitis using ursodeoxycholic acid.

We treated 82 patients of chronic hepatitis using 300 mg. of ursodeoxycholic acid (UDCA) daily and observed them for a mean of 10 mo before and 16 mo after UDCA administration. Seven liver function tests (AST, ALT, ALP, LAP, GTP, Ch-E and T-cholest) were assessed monthly. The values were compared before and after the administration of UDCA. The AST, ALT, LAP and GTP improved significantly in the UDCA treated patients, whereas ALP, Ch-E and T-cholest. did not show any change throughout the study. Amongst the liver function tests that improved, the serum--GTP level, in particular decreased markedly and rapidly in patients treated with UDCA. Although UDCA 600-mg daily was administered in patients who showed lack of improvement with 300-mg UDCA treatment, no significant improvement was obtained. Repeated liver biopsies were carried out in six of the 42 patients in whom liver biopsy had been performed before the administration of UDCA. We detected no histological changes during the UDCA treatment. There were no side effects related to therapy with UDCA. In conclusion, we confirmed that UDCA is a safe and effective drug for treating patients with chronic hepatitis and may help in prevention of progression of the disease, particularly in patients with a high serum--GTP level.

Adult↗
PubMedDate not supplied

Effect of age on the induction of endometrial lesions by a single intra-uterine administration of N-ethyl-N'-nitro-N-nitrosoguanidine in F344 rats.

A total of 54 10-week-old or 49 10-month-old female F344 rats were given a single intrauterine administration of 20 mg/kg N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG) dissolved in polyethylene glycol (PEG) via the vagina using a non-laparotomy approach. Control animals (32 10-week-old or 29 10-month-old rats) were given PEG alone in the same manner. The animals were killed at 15 and 18 months of age, respectively. One animal in the young treated group presented an endometrial adenocarcinoma (incidence: 2.1%), although the incidence and degree of endometrial hyperplasias were significantly increased in both groups of treated animals, as compared to corresponding controls. Histologically, many of these lesions were polypous glandular hyperplasias (adenomatous polyps) with stromal proliferation. The incidence and grade of proliferative lesions in the young treated group were slightly higher than those in the old treated group. ENNG administration did not appear to affect the hormonal situation in treated animals. These results indicate that young animals may be more sensitive to ENNG than aged ones for induction of endometrial lesions, although ENNG-treatment alone is not sufficient for early and high induction of carcinomas even in young rats of this strain.

Adenocarcinoma↗